{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:31:40Z","timestamp":1761183100250,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jiac.2022.02.020","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T22:25:08Z","timestamp":1646087108000},"page":"791-796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3698-5916","authenticated-orcid":false,"given":"Shingo","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misao","family":"Urushihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misuzu","family":"Yahaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshibumi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taka-aki","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8595-9381","authenticated-orcid":false,"given":"Hiroshi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Igari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.02.020_bib1","first-page":"129","article-title":"High effectiveness of SARS-CoV-2 vaccines in reducing COVID-19-related deaths in over 75-year-olds, ceara state, Brazil","volume":"6","author":"Alencar","year":"2021","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.jiac.2022.02.020_bib2","first-page":"2100420","volume":"26","author":"Fabiani","year":"2021"},{"key":"10.1016\/j.jiac.2022.02.020_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 vaccine: first approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2022.02.020_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First month of COVID-19 vaccine safety monitoring - United States, december 14, 2020-january 13, 2021","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2022.02.020_bib5","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1016\/j.vaccine.2021.10.019","article-title":"Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: findings from the CDC v-safe surveillance system","volume":"39","author":"Chapin-Bardales","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2022.02.020_bib6","doi-asserted-by":"crossref","first-page":"w30090","DOI":"10.4414\/SMW.2021.w30090","article-title":"Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study","volume":"151","author":"Guedel","year":"2021","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jiac.2022.02.020_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048109","article-title":"Active vaccine safety surveillance of seasonal influenza vaccination via a scalable, integrated system in Western Australian pharmacies: a prospective cohort study","volume":"11","author":"Salter","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiac.2022.02.020_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1527-3458.2006.00250.x","article-title":"Paracetamol: new vistas of an old drug","volume":"12","author":"Bertolini","year":"2006","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.jiac.2022.02.020_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1213\/00000539-200002000-00035","article-title":"The pharmacokinetics and analgesic efficacy of larger dose rectal acetaminophen (40 mg\/kg) in adults: a double-blinded, randomized study","volume":"90","author":"Beck","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jiac.2022.02.020_bib10","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa0907413","article-title":"Response to a monovalent 2009 influenza A (H1N1) vaccine","volume":"361","author":"Greenberg","year":"2009","journal-title":"N Engl J Med"},{"author":"Ikeda","key":"10.1016\/j.jiac.2022.02.020_bib12"},{"key":"10.1016\/j.jiac.2022.02.020_bib15","article-title":"Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021","author":"Ossato","year":"2021","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.jiac.2022.02.020_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fphar.2018.00539","article-title":"Characterization of the differential adverse event rates by race\/ethnicity groups for HPV vaccine by integrating data from different sources","volume":"9","author":"Huang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiac.2022.02.020_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1348-0421.2010.00254.x","article-title":"Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health-care workers of a university hospital in Japan","volume":"54","author":"Igari","year":"2010","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jiac.2022.02.020_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7883\/yoken.64.177","article-title":"Effectiveness and safety of pandemic influenza A (H1N1) 2009 vaccine in healthcare workers at a university hospital in Japan","volume":"64","author":"Igari","year":"2011","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jiac.2022.02.020_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1248\/yakushi.18-00160","article-title":"Adverse events after the introduction of quadrivalent influenza vaccine in comparison with AH1pdm vaccine (2009) in Japan","volume":"139","author":"Yamazaki","year":"2019","journal-title":"Yakugaku Zasshi"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2200068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2200068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:39Z","timestamp":1761159819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2200068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1341321X2200068X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.02.020","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}